MRK
Merck & Co., Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$149.52
+2.18%Price chart
Oct 1Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30
Key dataOct 30, 2026
Open$150.18
From 52W high−4.43%
Volume12.26M
Market cap$368.89B
P/E (TTM)118.7x
P/S (TTM)5.6x
Div yield2.27%
Key dataOct 30, 2026
Open
$150.18
From 52W high
−4.43%
Volume
12.26M
Market cap
$368.89B
ValuationView details →
P/E (Fwd)
17.3x
EV/EBITDA
29.9x
P/E (TTM)
118.7x
RSI (14)
57.7
MomentumView details →
1D Return
+2.18%
YTD Return
+42.63%
SummaryUpdated Sep 1, 2026
Merck & Co., Inc. (NYSE:MRK) is one of the world's largest pharmaceutical companies, founded in 1891 and headquartered in Kenilworth, New Jersey. Originally established as the American subsidiary of the German chemical company E. Merck, the company became independent during World War I and has since evolved into a global healthcare leader. Today, Merck operates as a diversified healthcare company serving patients worldwide through two primary business segments: pharmaceuticals for human health and animal health products. The company has built its reputation on developing breakthrough medicines and vaccines that address some of the most challenging diseases facing humanity.
Similar companies
Latest newsMore news →